drugset / Trial / NCT00672074

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

NCT00672074 ↗

Phase 2 Completed 117 enrolled Helsinn Therapeutics (U.S.), Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.

Timeline

Start
2008-04
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ipamorelin Protein / enzyme biologic 0.03 mg/kg Intravenous

Indications